Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation

We retrospectively reviewed the medical records of 75 allogeneic hematopoietic transplant recipients and evaluated cystatin C as a potential marker of subsequent renal dysfunction. Acute kidney injury developed in 31 of 75 patients after a median of 46 days post-transplantation (range 1–502 days), w...

Full description

Saved in:
Bibliographic Details
Published in:International journal of hematology Vol. 91; no. 3; pp. 471 - 477
Main Authors: Muto, Hideharu, Ohashi, Kazuteru, Ando, Minoru, Akiyama, Hideki, Sakamaki, Hisashi
Format: Journal Article
Language:English
Published: Japan Springer Japan 01-04-2010
Springer
Springer Nature B.V
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We retrospectively reviewed the medical records of 75 allogeneic hematopoietic transplant recipients and evaluated cystatin C as a potential marker of subsequent renal dysfunction. Acute kidney injury developed in 31 of 75 patients after a median of 46 days post-transplantation (range 1–502 days), while worsening of chronic kidney disease (CKD) was observed in 21 patients during the observational period. Cystatin C level was significantly elevated after allogeneic transplantation ( P  < 0.001). Multivariate analysis revealed the use of calcineurin inhibitors as a major cause of cystatin C elevation (odds ratio 7.26, P  = 0.04). A strong inverse correlation was also noted between cystatin C and estimated glomerular filtration rate ( r  = −0.682, P  < 0.001). Cystatin C measurement could provide a useful clinical tool to identify hematopoietic stem cell transplantation recipients at an increased risk for CKD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0925-5710
1865-3774
DOI:10.1007/s12185-010-0521-0